Micro-RNA Biogenesis Genes (AGO1 and GEMIN4) Single Nucleotide Variants of Bad Prognosis and Poor Therapeutic Response in Egyptian Chronic Myeloid Leukemia Patients: Case–control Study

Wafaa Abd Abdelghany; Mohamed Emam; Usama Elnagar; Rehab Helmy; Osama H. Korayem; Naglaa M. Hassan

doi:10.3889/oamjms.2021.6160

Authors

Wafaa Abd Abdelghany Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt https://orcid.org/0000-0001-6072-1318
Mohamed Emam Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
Usama Elnagar Department of Medical Oncology, WadiElneel Hospital, Cairo, Egypt
Rehab Helmy Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt https://orcid.org/0000-0003-3948-6477
Osama H. Korayem Department of Biotechnology and Life Sciences, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Beni-Suef, Egypt https://orcid.org/0000-0001-7793-2760
Naglaa M. Hassan Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt

DOI:

https://doi.org/10.3889/oamjms.2021.6160

Keywords:

Chronic myeloid leukemia, Clinical, Prognosis, Therapy, Variants

Abstract

BACKGROUND: Chronic myeloid leukemia (CML) is one of the most common hematological tumors. Gene candidate studies cleared the association of single genetic variants (SNVs) to the risk and progression in CML. MicroRNA biogenesis genes disruption contributes a fundamental role in carcinogenesis.

AIM: We aimed to determine the association between rs636832 and rs2740348 SNVs of AGO1 gene and GEMIN4 gene, respectively, and the risk and prognosis in CML Egyptian patients with 5 years survival estimation.

METHODS: The study was conducted on 110 newly diagnosed CML patients and 110 age and sex healthy matched controls. Real-time polymerase chain reaction utilizing TaqMan probes was operated to demonstrate genetic modalities of rs636832 and rs2740348.

RESULTS: No significance difference was observed between the cases and controls regarding the genotypic and allelic frequencies for both variants. On the other hand, the rs636832 GG genotype was more evident at a younger age of diagnosis and associated with the poor grades of the Sokal and Eutos scores. As well, rs2740348 CC genotype was encountered in high Eutos score levels. Regarding the response therapy, rs636832 GG genotype was overrepresented in the resistance to Imatinib while rs2740348 CC genotype was prevalent in the resistance to both Imatinib and Nilotinib. Overall survival was of no statistical significance for both variants.

CONCLUSION: Our study revealed that the major homozygous genotypes of both variants were associated with bad prognostic clinical scores and poor response to therapy but with no role in CML risk.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Edatharaa PM, Gorreb M, Kagitac S, Cingeethamd A, Annamanenia S, Digumartic R, et al. Influence of caspase-9 polymorphisms on the development of chronic myeloid leukemia-a case-control study. Gene. 2019;1:100002. https://doi.org/10.1016/j.gene.2018.100002 DOI: https://doi.org/10.1016/j.gene.2018.100002

Hoffmann VS, Baccarani M, Hasford J, Lindoerfer D, Burgstaller S, Sertic D, et al. The EUTOS population-based registry: Incidence and clinical characteristics of 2904 CML patients in 20 European countries. Leukemia. 2015;29(6):1336-43. https://doi.org/10.1038/leu.2015.73 DOI: https://doi.org/10.1038/leu.2015.73

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. PMid:29313949 DOI: https://doi.org/10.3322/caac.21442

World Health Organization. Egypt-global Cancer Observatory. Geneva: World Health Organization; 2019. p. 1-2. Available from: https://gco.iarc.fr/today/data/factsheets/populations/818-egypt-fact-sheets.pdf.

Bruzzoni-Giovanelli H, González JR, Sigaux F, Villoutreix BO, Cayuela JM, Guilhot J, et al. Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia. Oncotarget. 2015;6(34):36269-77. https://doi.org/10.18632/ oncotarget.5915 PMid:26474455 DOI: https://doi.org/10.18632/oncotarget.5915

Dzikiewicz-Krawczyk A. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies. Crit Rev Oncol Hematol. 2015;93(1):1-17. https://doi.org/10.1016/j.critrevonc.2014.08.006 PMid:25217091 DOI: https://doi.org/10.1016/j.critrevonc.2014.08.006

Alves R, Gonçalves AC, Jorge J, Marques G, Luís D, Ribeiro AB, et al. MicroRNA signature refine response prediction in CML. Sci Rep. 2019;9:9666. https://doi.org/10.1038/s41598-019-46132-9 DOI: https://doi.org/10.1038/s41598-019-46132-9

Arribas-Hernández L, Kielpinski LJ, Brodersen P. mRNA decay of most arabidopsismiRNA targets requires slicer activity of AGO1. Plant Physiol. 2016;171(4):2620-32. https://doi.org/10.1104/pp.16.00231 PMid:27208258 DOI: https://doi.org/10.1104/pp.16.00231

Gutiérrez-Malacatt H, Ayala-Sanchez M, Aquino-Ortega X, Dominguez-Rodriguez J, Martinez-Tovar A, Olarte-Carrillo I, et al. The rs61764370 functional variant in the KRAS oncogene is associated with chronic myeloid leukemia risk in women. Asian Pac J Cancer Prev. 2016;17(4):2265-70. https://doi.org/10.7314/apjcp.2016.17.4.2265 PMid:27221928 DOI: https://doi.org/10.7314/APJCP.2016.17.4.2265

Song X, Zhong H, Wu Q, Wang M, Zhou J, Zhou Y, et al. Association between SNPs in microRNA machinery genes and gastric cancer susceptibility, invasion, and metastasis in Chinese Han population. Oncotarget. 2017;8(49):86435-46. https://doi.org/10.18632/oncotarget.21199 PMid:29156806 DOI: https://doi.org/10.18632/oncotarget.21199

Kim JS, Choi Y, Jin G, Kang HG, Choi JE, Jeon HS, et al. Association of a common AGO1 variant with lung cancer risk: A two-stage case-control study. Mol Carcinog. 2010;49(10):913-21. https://doi.org/10.1002/mc.20672 PMid:20721975 DOI: https://doi.org/10.1002/mc.20672

Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res. 2008;14(23):7956-62. https://doi.org/10.1158/1078-0432.ccr-08-1199 PMid:19047128 DOI: https://doi.org/10.1158/1078-0432.CCR-08-1199

Bermisheva MA, Takhirova ZR, Gilyazova IR, Khusnutdinova EK. MicroRNA biogenesis pathway gene polymorphisms are associated with breast cancer risk. Hum Genat. 2018;54(5):568-75. https://doi.org/10.1134/s1022795418040051 DOI: https://doi.org/10.1134/S1022795418040051

Wu G, Fan F, Hu P, Wang C. AGO1 enhances the proliferation and invasion of cholangiocarcinoma via the EMT-associated TGF-β _signaling pathway. Am J Transl Res. 2020;12(6):2890-902. PMid:32655817

Grassi S, Palumbo S, Mariotti V, Liberati D, Guerrini F, Ciabatti E, et al. The WNT pathway is relevant for the BCR-ABL1- independent resistance in chronic myeloid leukemia. Front Oncol. 2019;9:532. https://doi.org/10.3389/fonc.2019.00532 PMid:31293972 DOI: https://doi.org/10.3389/fonc.2019.00532

Bibi S, Arslanhan MD, Langenfeld F, Jeanningros S, Cerny- Reiterer S, Hadzijusufovic E, et al. Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: Possible new targets of therapy. Haematologica. 2014;99(3):417-29. https://doi.org/10.3324/haematol.2013.098442 PMid:24598853 DOI: https://doi.org/10.3324/haematol.2013.098442

Yang J, Fuller PJ, Morgan J, Shibata H, Clyne CD, Young MJ. GEMIN4 functions as a coregulator of the mineralocorticoid receptor. J Mol Endocrinol. 2015;54:149-60. https://doi.org/10.1530/jme-14-0078 PMid:25555524 DOI: https://doi.org/10.1530/JME-14-0078

Luo W, Song L, Chen XL, Zeng XF, Wu JZ, Zhu CR, et al. Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells. Oncotarget. 2016;7(18):26709-23. https://doi.org/10.18632/oncotarget.8489 PMid:27050374 DOI: https://doi.org/10.18632/oncotarget.8489

Su YL, Luo HL, Huang CC, Liu TT, Huang EY, Sung MT, et al. Galectin-1 overexpression activates the FAK/PI3K/AKT/ mTOR pathway and is correlated with upper urinary urothelial carcinoma progression and survival. Cells. 2020;9(4):806. https://doi.org/10.3390/cells9040806 PMid:32225123 DOI: https://doi.org/10.3390/cells9040806

Hochhaus A, Saussele S, Rosti G, Mahon FX, Janssen JJ, Hjorth-Hansen H, et al. Chronic myeloid leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(4):iv261. PMid:28881915 DOI: https://doi.org/10.1093/annonc/mdy159

Baba SM, Shah ZA, Javaid K, Pandith AA, Rasool J, Geelani SA, et al. Methylene tetrahydrofolate reductase gene C677T and A1298C polymorphic sequence variations influences the susceptibility to chronic myeloid leukemia in Kashmiri population. Front Oncol. 2019;24(9):612. https://doi.org/10.3389/fonc.2019.00612 PMid:31396477 DOI: https://doi.org/10.3389/fonc.2019.00612

Zapata C. Linkage disequilibrium measures for fine-scale mapping of disease loci are revisited. Front Genet. 2013;4:228. https://doi.org/10.3389/fgene.2013.00228 PMid:24204380 DOI: https://doi.org/10.3389/fgene.2013.00228

Berger S, Schlather M, de los Campos G, Weigend S, Preisinger R, Erbe M, et al. A scale-corrected comparison of linkage disequilibrium levels between genic and non-genic regions. PLoS One. 2015;10(10):e0141216. https://doi.org/10.1371/journal.pone.0141216 PMid:26517830 DOI: https://doi.org/10.1371/journal.pone.0141216

Thompson PA, Kantarjian HM, Cortes JE. Diagnosis and treatment of chronic myeloid leukemia in 2015. Mayo Clin Proc. 2015;90(10):1440-54. https://doi.org/10.1016/j.mayocp.2015.08.010 PMid:26434969 DOI: https://doi.org/10.1016/j.mayocp.2015.08.010

Fang X, Yin Z, Li X, Xia L, Zhou B. Polymorphisms in GEMIN4 and AGO1 genes are associated with the risk of lung cancer: A case-control study in Chinese female non-smokers. Int J Environ Res Public Health. 2016;13(10):939. https://doi.org/10.3390/ijerph13100939 PMid:27669275 DOI: https://doi.org/10.3390/ijerph13100939

Liu J, Liu J, Wei M, He Y, Liao B, Liao G, et al. Genetic variants in the MicroRNA machinery gene GEMIN4 are associated with risk of prostate cancer: A case-control study of the Chinese Han population. DNA Cell Biol. 2012;31(7):1296-302. https://doi.org/10.1089/dna.2011.1600 PMid:22506892 DOI: https://doi.org/10.1089/dna.2011.1600

Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X. Evaluation of genetic variants in microRNA related genes and risk of bladder cancer. Cancer Res. 2008;68(7):2530-7. https://doi.org/10.1158/0008-5472.can-07-5991 PMid:18381463 DOI: https://doi.org/10.1158/0008-5472.CAN-07-5991

He Y, Zhou Y, Xi Q, Cui H, Luo T, Song H, et al. Genetic variations in MicroRNA processing genes are associated with susceptibility in depression. DNA Cell Biol. 2012;31(9):1499-506. https://doi.org/10.1089/dna.2012.1660 PMid:22694265 DOI: https://doi.org/10.1089/dna.2012.1660

Zhu W, Zhao J, He J, Qi D, Wang L, Ma X, et al. Genetic variants in the MicroRNA biosynthetic pathway Gemin3 and Gemin4 are associated with a risk of cancer: A meta-analysis. PeerJ. 2016;4:e1724. https://doi.org/10.7717/peerj.1724 PMid:27019773 DOI: https://doi.org/10.7717/peerj.1724